The clinical symptoms of HPP in children with variant(s) in the ALPL gene in the Russian population were most fully described in only 56 of the patients, and clinical information was available for 22 compound heterozygotes carriers of the causal variants in these patients (Table 1, Figure 1). The gene discussed is ALPL; the disease is hypophosphatasia.